pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 13·1 min read
save

Doctors link infant's brain tumor to gene therapy virus in rare case

May 13, 2026·read at STAT ↗Neutral

Doctors treated 13-month-old Adam with an experimental gene therapy after his stem cell transplant failed, and the boy subsequently reached developmental milestones such as learning sign language and reading.

A routine scan later revealed a golf‑ball sized tumor in his brain. Physicians examined the case and concluded that the tumor was associated with the viral vectors used in the gene therapy, marking a rare documented link.

Medical experts caution that while such adverse events are extremely uncommon, they must be balanced against the profound benefits gene therapies can provide for patients with life‑threatening rare diseases.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Scientists link boy’s tumor to gene therapy viruses, in rare finding”

read at STAT ↗
446 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.8
drugs
Rare Disease3
topics
Gene Therapy (AAV)10Rare Disease8Oncology6CRISPR/Cas92

related stories

  • 5d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Jul 8Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversalBioPharma Dive
  • Jul 2STAT+: A year after distressed buyout, what’s become of Bluebird Bio?STAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive